Exploring Prognostic Implications of MiRNA Signatures and Telomere Maintenance Genes in Kidney Cancer

Overview

Journal Mol Ther Oncol

Date 2024 Oct 14

PMID 39399813

Authors

Srinivasulu Yerukala Sathipati

Sohyun Jeong

Param Sharma

John Mayer

Rohit Sharma

Shinn-Ying Ho

Scott Hebbring

Affiliations

Soon will be listed here.

Abstract

Kidney cancer, particularly clear cell renal cell carcinoma (KIRC), presents significant challenges in disease-specific survival. This study investigates the prognostic potential of microRNAs (miRNAs) in kidney cancers, including KIRC and kidney papillary cell carcinoma (KIRP), focusing on their interplay with telomere maintenance genes. Utilizing data from The Cancer Genome Atlas, miRNA expression profiles of 166 KIRC and 168 KIRP patients were analyzed. An evolutionary learning-based kidney survival estimator identified robust miRNA signatures predictive of 5-year survival for both cancer types. For KIRC, a 37-miRNA signature showed a correlation coefficient (R) of 0.82 and mean absolute error (MAE) of 0.65 years. Similarly, for KIRP, a 23-miRNA signature exhibited an R of 0.82 and MAE of 0.64 years, demonstrating comparable predictive accuracy. These signatures also displayed diagnostic potential with receiver operating characteristic curve values between 0.70 and 0.94. Bioinformatics analysis revealed targeting of key telomere-associated genes such as , , , and by these miRNAs, implicating crucial pathways such as cellular senescence and proteoglycans in cancer. This study highlights the significant link between miRNAs and telomere genes in kidney cancer survival, offering insights for therapeutic targets and improved prognostic markers.

References

Harries L . MicroRNAs as Mediators of the Ageing Process. Genes (Basel). 2014; 5(3):656-70. PMC: 4198923. DOI: 10.3390/genes5030656. View

Yerukala Sathipati S, Aimalla N, Tsai M, Carter T, Jeong S, Wen Z . Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma. Carcinogenesis. 2023; 44(8-9):650-661. DOI: 10.1093/carcin/bgad062. View

Ho S, Chen J, Huang M . Inheritable genetic algorithm for biobjective 0/1 combinatorial optimization problems and its applications. IEEE Trans Syst Man Cybern B Cybern. 2004; 34(1):609-20. DOI: 10.1109/tsmcb.2003.817090. View

OBrien J, Hayder H, Zayed Y, Peng C . Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018; 9:402. PMC: 6085463. DOI: 10.3389/fendo.2018.00402. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Yerukala Sathipati S, Tsai M, Shukla S, Ho S, Liu Y, Beheshti A . MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma. Sci Rep. 2022; 12(1):4141. PMC: 8907292. DOI: 10.1038/s41598-022-08082-7. View

Motzer R, Jonasch E, Agarwal N, Bhayani S, Bro W, Chang S . Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017; 15(6):804-834. DOI: 10.6004/jnccn.2017.0100. View

Shay J, Wright W . Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019; 20(5):299-309. DOI: 10.1038/s41576-019-0099-1. View

Ying G, Wu R, Xia M, Fei X, He Q, Zha C . Identification of eight key miRNAs associated with renal cell carcinoma: A meta-analysis. Oncol Lett. 2018; 16(5):5847-5855. PMC: 6176358. DOI: 10.3892/ol.2018.9384. View

10.

Yerukala Sathipati S, Sahu D, Huang H, Lin Y, Ho S . Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma. Sci Rep. 2019; 9(1):5125. PMC: 6435792. DOI: 10.1038/s41598-019-41553-y. View

11.

Chow T, Youssef Y, Lianidou E, Romaschin A, Honey R, Stewart R . Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem. 2009; 43(1-2):150-8. DOI: 10.1016/j.clinbiochem.2009.07.020. View

12.

Yin Q, Zhao Y, Ni W, Tang T, Wang Y, Cao J . MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury. Theranostics. 2022; 12(10):4753-4766. PMC: 9254246. DOI: 10.7150/thno.72456. View

13.

Chen C, Cheng C, Chen Y, Sue Y, Liu C, Cheng T . MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis. PLoS One. 2014; 9(6):e99802. PMC: 4068774. DOI: 10.1371/journal.pone.0099802. View

14.

Xiao X, Tang C, Xiao S, Fu C, Yu P . Enhancement of proliferation and invasion by MicroRNA-590-5p via targeting PBRM1 in clear cell renal carcinoma cells. Oncol Res. 2013; 20(11):537-44. DOI: 10.3727/096504013X13775486749335. View

15.

Westhoff J, Schildhorn C, Jacobi C, Homme M, Hartner A, Braun H . Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol. 2009; 21(2):327-36. PMC: 2834551. DOI: 10.1681/ASN.2009010072. View

16.

Yerukala Sathipati S, Tsai M, Aimalla N, Moat L, Shukla S, Allaire P . An evolutionary learning-based method for identifying a circulating miRNA signature for breast cancer diagnosis prediction. NAR Genom Bioinform. 2024; 6(1):lqae022. PMC: 10894035. DOI: 10.1093/nargab/lqae022. View

17.

Yamada Y, Arai T, Kojima S, Sugawara S, Kato M, Okato A . Anti-tumor roles of both strands of the duplex: their targets and are involved in the pathogenesis of renal cell carcinoma. Oncotarget. 2018; 9(42):26638-26658. PMC: 6003567. DOI: 10.18632/oncotarget.25410. View

18.

Sieverling L, Hong C, Koser S, Ginsbach P, Kleinheinz K, Hutter B . Genomic footprints of activated telomere maintenance mechanisms in cancer. Nat Commun. 2020; 11(1):733. PMC: 7002710. DOI: 10.1038/s41467-019-13824-9. View

19.

Donderski R, Szczepanek J, Naruszewicz N, Naruszewicz R, Tretyn A, Skoczylas-Makowska N . Analysis of profibrogenic microRNAs (miRNAs) expression in urine and serum of chronic kidney disease (CKD) stage 1-4 patients and their relationship with proteinuria and kidney function. Int Urol Nephrol. 2021; 54(4):937-947. PMC: 8924094. DOI: 10.1007/s11255-021-02928-1. View

20.

Licursi V, Conte F, Fiscon G, Paci P . MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinformatics. 2019; 20(1):545. PMC: 6829817. DOI: 10.1186/s12859-019-3105-x. View